Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.
Lavigne JE, Shearer WT, Thompson B, Orav EJ, Starc TJ, Colan SD, Pignatelli R, O'Brien SE, Bezold L, LaRusa P, Easley KA, Cheng I, Duffy SA, Lipshultz SE; CHAART Study Group.
Lavigne JE, et al. Among authors: cheng i.
Cardiovasc Toxicol. 2004;4(2):187-97. doi: 10.1385/ct:4:2:187.
Cardiovasc Toxicol. 2004.
PMID: 15371634
Clinical Trial.